Skip to main content
Zachary Freyberg, MD, Psychiatry, Pittsburgh, PA

Zachary Freyberg MD PhD


Assistant Professor

Join to View Full Profile
  • 3811 Ohara St# W1640Pittsburgh, PA 15213

  • Phone+1 412-648-0033

  • Fax+1 212-746-8800

Dr. Freyberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Psychiatry, 2004 - 2011
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 2004

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2016 - 2026
  • NY State Medical License
    NY State Medical License 2005 - 2020
  • Psychiatry
    American Board of Psychiatry and Neurology Psychiatry

Publications & Presentations

PubMed

Press Mentions

  • Study Uncovers Genetic Variants Linked to Disease Progression
    Study Uncovers Genetic Variants Linked to Disease ProgressionMay 10th, 2021
  • A Single Protein Might Be Key to Slowing the Aging Process
    A Single Protein Might Be Key to Slowing the Aging ProcessApril 29th, 2021
  • Study Finds Link Between Antipsychotic Drugs, Weight Gain
    Study Finds Link Between Antipsychotic Drugs, Weight GainMarch 13th, 2021
  • Join now to see all

Grant Support

  • Novel roles for the circadian transcription factor NPAS2 and striatal dopamine D3 receptor signaling in diurnal fentanyl craving and relapseUNIV OF MASSACHUSETTS MED SCH WORCESTER2024–2029
  • Novel roles for the circadian transcription factor NPAS2 and striatal dopamine D3 receptor signaling in diurnal fentanyl craving and relapseUNIV OF MASSACHUSETTS MED SCH WORCESTER2024–2029
  • Novel roles for the circadian transcription factor NPAS2 and striatal dopamine D3 receptor signaling in diurnal fentanyl craving and relapseUNIV OF MASSACHUSETTS MED SCH WORCESTER2024–2029
  • Novel roles for the circadian transcription factor NPAS2 and striatal dopamine D3 receptor signaling in diurnal fentanyl craving and relapseUNIV OF MASSACHUSETTS MED SCH WORCESTER2024–2029
  • Novel roles for the circadian transcription factor NPAS2 and striatal dopamine D3 receptor signaling in diurnal fentanyl craving and relapseUNIV OF MASSACHUSETTS MED SCH WORCESTER2024–2029
  • Novel roles for the circadian transcription factor NPAS2 and striatal dopamine D3 receptor signaling in diurnal fentanyl craving and relapseUNIV OF MASSACHUSETTS MED SCH WORCESTER2024–2029
  • Novel roles of VGLUT in sex differences in dopamine neuron vulnerability to environmental toxicant-induced neurodegenerationUNIVERSITY OF PITTSBURGH AT PITTSBURGH2023–2027
  • Novel roles of VGLUT in sex differences in dopamine neuron vulnerability to environmental toxicant-induced neurodegenerationUNIVERSITY OF PITTSBURGH AT PITTSBURGH2023–2027
  • Novel roles of VGLUT in sex differences in dopamine neuron vulnerability to environmental toxicant-induced neurodegenerationUNIVERSITY OF PITTSBURGH AT PITTSBURGH2023–2027
  • Novel roles of VGLUT in sex differences in dopamine neuron vulnerability to environmental toxicant-induced neurodegenerationUNIVERSITY OF PITTSBURGH AT PITTSBURGH2023–2027
  • Novel dopaminergic mechanisms of islet hormone secretion and antipsychotic drug-induced metabolic disturbancesUNIVERSITY OF PITTSBURGH AT PITTSBURGH2021–2025
  • Ultra-fast high-resolution imaging of whole mouse brain for the study of drug addictionUNIVERSITY OF PITTSBURGH AT PITTSBURGH2021–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: